Literature DB >> 1697397

Prevention of spontaneous diabetes in BB rats with FK 506.

N Murase, I Lieberman, M Nalesnik, D Mintz, S Todo, A L Drash, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1697397     DOI： 10.1016/0140-6736(90)91913-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

2.  Treatment of Cogan's syndrome with FK 506: a case report.

Authors:  M I Roat; R A Thoft; A W Thomson; A Jain; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.

Authors:  L Mieles; R D Gordon; D Mintz; R M Toussaint; O Imventarza; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 4.  FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors:  A W Thomson; P B Carroll; J McCauley; J Woo; K Abu-Elmagd; T E Starzl; D H Van Thiel
Journal:  Springer Semin Immunopathol       Date:  1993

5.  Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin.

Authors:  F Nicoletti; M O Borghi; P L Meroni; W Barcellini; C Fain; R Di Marco; R Menta; H U Schorlemmer; G Bruno; G Magro
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

6.  The BBZ/Wor rat: clinical characteristics of the diabetic syndrome.

Authors:  D L Guberski; L Butler; S M Manzi; M Stubbs; A A Like
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.